Immunoassay Market Growth Rate 2022,Supply with Regional Forecast to 2028

According to the new market research report Immunoassay Market is expected to reach USD 27.15 Billion by 2023 from USD 20.19 Billion in 2018, at a CAGR of 6.1%.Ask For Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436The increasing incidence of chronic and infectious diseases, technological advancements in immunoassay instruments and introduction of novel automated systems, and growth in the biotechnology and biopharmaceutical industries are some the major factors driving the growth of this market.North America held the largest share of the market in 2017Based on region, the immunoassay market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America dominated the market in 2017.

The large share of this regional segment is attributed to the increasing incidence of chronic diseases and improved healthcare infrastructure.The chemiluminescence immunoassays (CLIAs) segment led the immunoassay market in 2017By platform, this market is classified into CLIAs, radioimmunoassays (RIAs), colorimetric immunoassays (CIs), fluorescence immunoassays (FIAs), and other platforms.

The CLIAs segment accounted for the largest share of the immunoassay market in 2017.

The large share of this segment can primarily be attributed to the low cost and high sensitivity of CLIA-based tests.By product and service, the reagents and kits segment commanded the largest share of the market in 2017On the basis product and service, this market is classified into reagents and kits, analyzers, and software and services.

In 2017, the reagents and kits segment accounted for the largest share of the immunoassay systems market.

Immunoassay Market Overview:Immunoassay Market, as reported in the latest study of the market by Market Research Future (MRFR), is expecting a growth by 8.5% CAGR during the forecast period (2017-2023).

Immunoassays find much traction in the healthcare sector for their ability to find results rapidly and accuracy.Growing biotechnology and pharmaceutical sectors, across the globe, is all set to provide stimulants for the market growth.

Oncology department is also gaining much benefits from its use and concerns regarding the prevalence of cancer can be considered a serious factor.Key Questions Answered in This Report:What will the market size and what will the growth rate be?What are the key market trends?What is driving this market?What are the challenges to market growth?Who are the key vendors in this market space?Get Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5841Segmentation: The report also has its focus on segmental analysis that includes detailed volume-wise and value-wise analysis.

MRFR segments the global immunoassay market by product and service, type, and end-user.Based on the product and service, the immunoassay market can be segmented into reagents and kits, analyzers, and software and services.

The analyzers segment can be segmented into portable analyzers and benchtop analyzers.Based on the type, the immunoassay market can be segmented into Enzyme Immunoassays (EIA) or Enzyme-Linked Immunosorbent Assays (ELISA), Radioimmunoassay (RIA), Fluoroimmunoassay (FIA), Counting Immunoassay (CIA), and Chemiluminescence immunoassay (CLIA).Based on the application, the immunoassay market can be segmented into infectious diseases, autoimmune disorders, oncology, neonatal screening, toxicology, hematology & blood screening, cardiology, bone & mineral disorders, and others.Based on the end-user, the immunoassay market includes biotechnology companies, diagnostic laboratories, research & academic laboratories, hospitals & clinics, pharmaceutical companies, and others.Some Brief Table of Contents of ReportChapter 1.

Market Dynamics4.1 Drivers4.2 Restrains4.3 Opportunities4.4 Challenges4.5 Macroeconomic Indicators4.6 Technology Trends & AssessmentChapter 5.

The global market for immunoassay is fragmented in nature with a high number of players engaged in it across the globe, states a new research report by Transparency Market Research.

The rapid development of the healthcare sector and the increasing investments by the leading players, especially for research and development activities, which is estimated to enhance the market development and strengthen the competitive scenario of the market over the next few years.

Moreover, the rising number of partnerships and mergers and the technological developments in this area are projected to enhance the growth of the global immunoassay market in the coming few years.

The leading players operating in the immunoassay market across the globe are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, BioMérieux SA, Becton, Dickinson and Company, DiaSorin S.p.A., Sysmex Corporation, Ortho Clinical Diagnostics, and Danaher Corporation.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=19703As per the research report, in 2017, the global market for immunoassay stood at US$ 16.54 Bn and is estimated to reach a value of US$ 28.61 Bn by the end of 2026.

The North America market for immunoassay is estimated to hold a key share of the market, further followed by Europe.

The strong growth of Europe and North America can be ascribed to the presence of well-established healthcare infrastructure and the development of the biotechnology industry.Growing Adoption of Immunoassay in Oncology to Ensure Market GrowthA significant rise in the incidence of infectious and chronic diseases and the tremendously rising geriatric population are the key factors encouraging the growth of the global immunoassay market in the next few years.